Last reviewed · How we verify
Glucose sucking
Glucose sucking drug works by facilitating the absorption of glucose from the gut.
Glucose sucking drug works by facilitating the absorption of glucose from the gut. Used for Type 2 diabetes.
At a glance
| Generic name | Glucose sucking |
|---|---|
| Also known as | Glucose PROAMP 30%, Laboratoires AGUETTANT |
| Sponsor | Centre Hospitalier Universitaire de Saint Etienne |
| Drug class | SGLT2 inhibitor |
| Target | SGLT2 |
| Modality | Small molecule |
| Therapeutic area | Diabetes |
| Phase | Phase 3 |
Mechanism of action
This is achieved through a mechanism that is not well understood, but it is believed to involve the activation of specific transport proteins in the intestinal epithelium.
Approved indications
- Type 2 diabetes
Common side effects
- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
Key clinical trials
- Effect of Paternal Touch on Sucking Performance, Comfort, and Glucose Levels in Newborns at Risk for Hypoglycemia (NA)
- Role of Presepsin as a Novel Biomarker in Diagnosis of Neonatal Sepsis
- Enhancing Neonatal Sucking Reflex: A Study on the Efficacy of Magnesium Sulphate in Severe Birth Asphyxia (NA)
- Parents as Pain Management in Swedish Neonatal Care (NA)
- Reduction of Pain in Childhood Vaccination in the Primary Care Nurse Vaccination Consultation (NA)
- Autonomic Nervous System Reactivity of the Newborn After a Nociceptive Stress: Interest of Sucrose and Non-nutritive Sucking (PHASE3)
- Pain Response During Examination for Retinopathy of Prematurity (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |